Arisugacins, selective acetylcholinesterase inhibitors of microbial origin

Pharmacology and Therapeutics

Volumn 76, Issue 1-3, 1997, Pages 45-54

  Otoguro, Kazuhiko ^a   Kuno, Fumiyoshi ^a   Omura, Satoshi ^a  

^a KITASATO INSTITUTE   (Japan)

Author keywords

Alzheimer's disease; Antidementia drugs; Arisugacin A; Microbial metabolites; Selective acetylcholinesterase inhibitors

Indexed keywords

1,5 BIS(4 ALLYLDIMETHYLAMMONIUMPHENYL)PENTAN 3 ONE DIBROMIDE; 2 (2 OXO 1 PYRROLIDINYL) N (5,6,7,8 TETRAHYDRO 2,3 DIMETHYLFURO[2,3 B]QUINOLIN 4 YL)ACETAMIDE; 2,8 DIMETHYL 3 METHYLENE 1 OXA 8 AZASPIRO[4.5]DECANE; 9 AMINO 8 FLUORO 1,2,3,4 TETRAHYDRO 2,4 METHANOACRIDINE; AMIRIDINE; ARISUGACIN A; ARISUGACIN B; ARISUGACIN DERIVATIVE; CGA 134735; CGA 134736; CHOLINERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE INHIBITOR; CYCLOPENIN; CYCLOPHOSTIN; DIMPYLATE; DONEPEZIL; I 6123; MYCELIANAMIDE; NEFIRACETAM; PHYSOSTIGMINE; RIVASTIGMINE; SNK 508; TACRINE; TACRINE DERIVATIVE; TERPENOID DERIVATIVE; TERRITREM B; TERRITREM C; UNCLASSIFIED DRUG; UNINDEXED DRUG; VELNACRINE; ZANEPEZIL;

ALZHEIMER DISEASE; CHOLINESTERASE INHIBITION; CLINICAL TRIAL; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION;

ACETYLCHOLINESTERASE; ALZHEIMER DISEASE; ANIMALS; ANTIPSYCHOTIC AGENTS; CHOLINESTERASE INHIBITORS; DRUG EVALUATION; DRUG EVALUATION, PRECLINICAL; HUMANS; PENICILLIUM; PYRANS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031277576     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(97)00093-4     Document Type: Review

References (63)

1. Arvanov, V. L., Ling, K. H. Chen, R.-C. and Tsai, M.C (1993) Effect of territrem-B on cholinergic responses of snail neuron. Neurosci. Lett. 152:69-71.
2. Bessho, T., Oshima, C., Saito, K., Egawa, M. and Tobe, A (1993) Effects of MKC-231, novel choline uptake enhancer, on AF64A-induced high affinity choline uptake and impairment of water maze learning in rats. Jpn. J. Pharmacol. 61 (Suppl.): 90.
3. Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I. and Selkoe, D. J. (1992) Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 360: 672-674.
4. Court, J. A. and Perry, E. K. (1991) Dementia: the neurochemical basis of putative transmitter orientated therapy. Pharmacol. Ther. 52: 423-443.
5. Cross, A. J., Crow, T. J., Ferrier, I. N., Johnson, J. A., Bloom, S. R. and Corsellis, J. A. N. (1984) Serotonin receptor changes in dementia of the Alzheimer type J. Neurochem. 43: 1574-1581.
6. Davies, P. (1979) Neurotransmitter-related enzyme in senile dementia of the Alzheimer type. Brain Res. 171: 319-327.
7. Davies, P. and Maloney, A. J. F. (1976) Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2: 1403.
8. Davis, K. L. and Powchik, P. (1995) Tacrine. Lancet 345: 625-630.
9. De Souza, E. B., Whitehouse, P. J. Kuhar, M. J., Price, D. L. and Vale, W. W. (1986) Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptor in cerebral cortex of Alzheimer's disease. Nature 319: 593-595.
10. Dowd, P. F., Peng, F. C., Chen, J. W. and Ling, K. H. (1992) Toxicity and anticholinesterase activity of the fungal metabolites territrems to the corn earworm, Helicoverpa zea. Entomol. Exp. Appl. 65: 57-64.
11. Enz, A., Amstutz, R., Hofmann, A., Gmelin, G. and Kelly, P. H. (1989) Pharmacological properties of the preferentially centrally acting acetylcholinesterase inhibitor SDZ-ENA-713. In: Pharmacological Interventions on Central Cholinergic Mechanisms in Senile Dementia (Alzheimer's Disease), pp. 271-277, Kewitz, H., Thomsen, T. and Bickel, M. (eds.) Zuckschwerdt Verlag, Munich.
12. Fenteany, G., Standaert, R. F., Lane, W. S., Choi, S., Corey, E. J. and Schreiber, S. L. (1995) Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268: 726-731.
13. Frautschy, S. A., Baird, A. and Cole, G. M. (1992) Effects of injected Alzheimer β-amyloid cores in rat brain Proc. Natl. Acad. Sci. USA 88: 8362-8366.
14. Health and Welfare Statistics Association (1996) Health care of the elderly. J. Health Welfare Stat. 48 (Suppl. 12): 234-235.
15. Hirai, K., Kato, K., Murakoshi, H., Ishihara, Y., Goto, G. and Miyamoto, M. (1993) Characteristics of neuropharmacological effects of TAK-147, a novel acetylcholinesterase inhibitor, in vitro. Soc. Neurosci. Abstr. 19: 1812.
16. Ishihara, Y., Hirai, K., Miyamoto, M. and Goto, G. (1994) Central cholinergic agents: 6. Synthesis and evaluation of 3-[1 phenyl-methyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1H-1-ben: azepin-8-yl)-1-propanones and their analogs as central selective acetylcholinesterase inhibitors. J. Med. Chem. 37: 2292-2299.
17. Iwasa, T., Harada, S. and Sato, Y. (1981) Miticidal antibiotics C-8030 B, C, D and physostigmine produced by Streptomyces pseudogriseolus subsp. iriomotensis subsp. nov. J. Takeda Res. Lab. 40: 12-26.
18. Kang, J., Lemaire, H. G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K., Multhaup, G., Beyreuther, K. and Muller-Hill, B. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733-736.
19. Kowall, N. W., Beal, M. F., Buscigmo, J., Duffy, L. K. and Yankner, B. A. (1991) An in vivo model for the neurodegenerative effects of β amyloid and protection by substance P. Proc. Natl. Acad. Sci. USA 88: 7247-7251.
20. Kuno, F., Otoguro, K., Shiomi, K., Iwai, Y. and Ōmura, S. (1996a) Arisugacins A and B, novel and selective acetylcholinesterase inhibitors from Penicillium sp. FO-4259: I. Screening, taxonomy, fermentation, isolation and biological activity. J. Antibiot. 49: 742-747.
21. Kuno, F., Shiomi, K., Otoguro, K., Sunazuka, T. and Ōmura, S. (1996b) Arisugacins A and B, novel and selective acetylcholinesterase inhibitors from Penicillium sp. FO-4259: II. Structure elucidation. J. Antibiot. 49: 748-751.
22. Kuribara, H. (1986) Effects of amiridin and ambulatory activity and discrete shuttle avoidance response in mice. Folia Pharmacol. Japn. 88: 299-307.
23. Kurokawa, T., Suzuki, K., Hayaoka, T. and Nakagawa, T. (1993) Cyclophostin, acetylcholinesterase inhibitor from Streptomyces lavendulae. J. Antibiot. 46: 1315-1318.
24. Lee, S. S., Peng, F.-C. and Ling, K. H. (1992) NMR assignments of territrems A, B, and C and the structure of MB2, the major metabolite of territrem B by rat liver microsomal fraction. J. Nat. Prod. 55: 251-255.
25. Ling, K. H., Yang, C.-K. and Peng, F.-T. (1979) Territrems, tremorgenic mycotoxins of Aspergillus terreus. Appl. Environ. Microbiol. 37: 355-357.
26. Ling, K. H., Liou, H.-H., Yang, C.-M. and Yang, C.-K. (1984) Isolation, chemical structure, acute toxicity, and some physicochemical properties of territrem C from Aspergillus terreus. Appl. Environ. Microbiol. 47: 98-100.
27. Lowe, S. L., Bowen, D. M. and Francis, P. T. (1990) Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease. Neuroscience 38: 571-578.
28. Maltby, N., Broe, G. A., Creasey, H., Jorm, A. F., Christensen, H. and Brooks, W. S. (1994) Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: double blind trial. Br. Med. J. 308: 879-883.
29. Mizutani, M. Y., Tomioka, N. and Itai, A. (1994) Rational automatic search method for stable docking models of protein and ligand. J. Mol. Biol. 243: 310-326.
30. Mohammed, Y. S. and Luckner, M. (1963) The structure of cyclopenin and cyclopenol, metabolic products from Penicillium cyclopium Westling and Penicillium viridicatum Westling. Tetrahedron Lett. 28: 1953-1958.
31. Mohs, R. C., Davis, K. L., Tinklenberg, J. R., Hollister, L. E., Yesavage, J. A. and Kopell, B. S. (1979) Choline chloride treatment of memory deficits in the elderly. Am. J. Psychiatry 136: 1275-1277.
32. Murao, S. and Hayashi, H. (1986) Physostigmine and N8-norphysostigmine, insecticidal compounds, from Streptomyces sp. Agric. Biol.Chem. 50: 523-524.
33. Nagasawa, T., Mori, N., Tani, Y. and Ogata, K. (1976) A butyryl-cholinesterase inhibitor produced by Penicillium sp. No. C-81 and its identity with mycelinamide. J. Antibiot. 29: 526-531.
34. Natori, K., Okasaki, Y., Irie, T. and Katsube, J. (1990) Pharmacological and biochemical assesment of SM-10888, a novel cholinesterase inhibitor. Jpn. J. Pharmacol. 53: 145-155.
35. Neumann, R. and Peter, H. H. (1987) Insecticidal organophosphates: nature made them first. Experientia 43: 1235-1237.
36. Ogata, K., Ueda, K., Nagasawa, T. and Tani, Y. (1974) A cholinesterase inhibitor produced by Aspergillus terreus J. Antibiot. 27: 343-345.
37. Okabe, H., Sagesaka, K., Noma, A. and Nakajima, N. (1977) Enzymatic assay of cholinesterase activity: II. Clinical application. Jpn. J. Clin. Pathol. 25: 755-758.
38. Ōmura, S. and Takeshima, H. (1996) Lactacystin: a tool for elucidation of proteasome functions. Protein Nucleic Acid Enzyme 41: 327-336.
39. Ōmura, S. and Tomoda, H. (1996) Lactacystin, a specific inhibitor of proteasome: from its discovery to its application. Cell Technol. 15: 929-940.
40. Ōmura, S., Fujimoto, T., Otoguro, K., Matsuzaki, K., Moriguchi, R., Tanaka, H. and Sasaki, Y. (1991a) Lactacystin, a novel microbial metabolite, induces neuritogenesis of neuroblastoma cell. J. Antibiot. 44: 113-116.
41. Ōmura, S., Matsuzaki, K., Fujimoto, T., Kosuge, K., Furuya, T., Fujita, A. and Nakagawa, A. (1991b) Structure of lactacystin, a new microbial metabolite which induces differentiation of neuroblastoma cell. J. Antibiot. 44: 117-118.
42. Ōmura, S., Tomoda, H., Kim, Y. K. and Nishida, H. (1993) Pyripyropenes, high potent inhibitors of acyl-CoA cholesterol acyltransferase produced by Aspergillus fumigatus. J. Antibiot. 46: 1168-1169.
43. Ōmura, S., Kuno, F., Otoguro, K., Sunazuka, T., Shiomi, K., Masuma, R. and Iwai, Y. (1995) Arisugacin, a novel and selective inhibitor of acetylcholinesterase from Penicillium sp. FO-4259. J. Antibiot. 48: 745-746.
44. Ono, S., Saito, Y., Ohgane, N., Kawanishi, G. and Mizobe, F. (1988) Heterogeneity of muscarinic autoreceptors and heteroreceptors in the rat brain: effects of a novel M1 agonist, AF102B. Eur. J. Pharmacol. 155: 77-84.
45. Pang, Y.-P., Quiram, P., Jelacic, T., Hong, F. and Brimijoin, S. (1996) Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase. J. Biol. Chem. 271: 23646-23649.
46. Peng, F. C. (1995) Acetylcholinesterase inhibition by territrem B derivatives. J. Nat. Prod. 58: 857-862.
47. Perry, R. H., Candy, J. M., Perry, E. K., Irving, D. Blessed, G., Fairbairn, A. F. and Tomlinson, B. E. (1982) Extensive loss choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease. Neurosci. Lett. 33: 311-315.
48. Relman, A. S. (1991) Tacrine as a treatment for Alzheimer's dementia. N. Engl. J. Med. 324: 349-352.
49. Sakurai, T., Ojima, H., Yamasaki, T., Kojima, H. and Akashi, A. (1989) Effects of N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamide (DM-9384) on learning and memory in rats. Jpn. J. Pharmacol. 50: 47-53.
50. Selkoe, D. J. (1991) The molecular pathology of Alzheimer's disease. Neuron 6: 487-498.
51. Shutske, G. M., Pierrat, F. A., Kapples, K. J., Cornfeldt, M. F., Szewczak, M. R., Huger, F. P., Bores, G. M., Haroutunian, V. and Davis, K. F. (1989) 9-Amino-1-2,3,4-tetrahydroacridin-1-ols: synthesis and evaluation as potential Alzheimer's disease therapeutics. J. Med. Chem. 32: 1805-1813.
52. Smith, R. D., Kistler, M. K., Chen-Williams, M. and Coffin, V. L. (1996) Cholinergic improvement of a naturally-occurring memory deficit in the young rat. Brain Res. 707: 13-21.
53. Storga, D., Vrecko, K., Birkmayer, J. G. and Reibnegger, G (1996) Monoaminergic neurotransmitters, their precursors and metabolites in brain of Alzheimer patients. Neurosci. Lett. 203: 29-32.
54. Sugimoto, H., Iimura, Y., Yamanishi, Y. and Yamatsu, K. (1995) Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan2-yl)methyl]piperidine hydrochloride and related compounds. J. Med. Chem. 38: 4821-4829.
55. Summers, W. K., Viesselman, J. O., Marsh, G. M. and Candelora, K. (1981) Use of THA in treatment of Alzheimer-like dementia: pilot study in twelve patient. Biol. Psychiatry 16: 145-153.
56. Summers, W. K., Majovski, L. V, Marsh, G. M., Tachiki, K. and King, A. (1986) Oral tetrahydroaminoacridine in long term treatment of senile dementia, Alzheimer type. N. Engl. J. Med. 315: 1241-1245.
57. Suzuki, N., Cheung, T. T., Cai, X.-D., Odaka, A., Otvos, L., Jr., Eckman, C., Golde, T. E. and Younkin, S. G. (1994) An increased percentage of long amyloid β-protein secreted by familial amyloid β-protein precursor (β APP717) mutants. Science 264: 1336-1340.
58. Taylor, P. (1991) The cholinesterases. J. Biol. Chem. 266: 4025-4028.
59. Thomsen, T., Zendeh, B., Fischer, J. P. and Kewitz, H. (1991) In vitro effects of various cholinesterase inhibitors on acetyl- and butyrylcholinesterase of healthy volunteers. Biochem. Pharmacol. 41: 139-141.
60. Tomoda, H., Tabata, K., Nakata, Y., Nishida, H., Kaneko, T., Obata, R., Sunazuka, T. and Ōmura, S. (1996) Biosynthesis of pypripyropene A. J. Org. Chem. 61: 882-886.
61. Ubillas, R., Barnes, C. L., Gracz, H., Rottinghaus, G. E., and Tempesta, M. S. (1989) X-Ray crystal structure of oxalicine A, a novel alkaloid from Penicillium cyclopium. J. Chem. Soc. Chem. Commun.: 1618-1619.
62. Wambuchi, F., Konishi, T., Harada, M., Terai, M., Hidaka, K., Tamura, T., Tsukamoto, S. and Usuda, S. (1990) Pharmacological studies on novel muscarinic agonists, 1-oxa-8-azaspiro[4.5]decane derivatives, YM796 and YM954. Eur. J. Pharmacol. 187: 479-486.
63. Yoshida, M., Hasegawa, M., Noda, Y. and Nabeshima, T. (1995) The domestic states of development of cognitive enhancers for senile dementia of Alzheimer's type. Dementia 9: 233-245.